ANI Pharmaceuticals, Inc. (ANIP) Earnings History
Annual and quarterly earnings data from 1998 to 2025
Loading earnings history...
ANIP EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
ANIP Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2025 | 0.0% | 12.6% | 8.9% |
| 2024 | 59.3% | 0.1% | -3.0% |
| 2023 | 62.7% | 9.6% | 3.9% |
| 2022 | 56.1% | -11.2% | -15.1% |
| 2021 | 53.5% | -18.4% | -19.7% |
Download Data
Export ANIP earnings history in CSV or JSON format
Free sign-in required to download data
ANI Pharmaceuticals, Inc. (ANIP) Earnings Overview
As of May 8, 2026, ANI Pharmaceuticals, Inc. (ANIP) reported trailing twelve-month net income of $78M, reflecting +419.2% year-over-year growth. The company earned $3.69 per diluted share over the past four quarters, with a net profit margin of 8.9%.
Looking at the long-term picture, ANIP's historical earnings data spans multiple years. The company achieved its highest annual net income of $78M in fiscal 2025, representing a new all-time high.
ANI Pharmaceuticals, Inc. maintains positive profitability with, operating margin of 12.6%, and net margin of 8.9%. The company continues to generate positive earnings from operations. View revenue history →
Compared to peers including AMRX ($72M net income, 2.4% margin), LNTH ($279M net income, 15.2% margin), PRGO (-$1.82B net income, -33.5% margin), ANIP has outperformed on profitability metrics. Compare ANIP vs AMRX →
ANIP Earnings vs Peers
Earnings metrics vs comparable public companies
ANIP Historical Earnings Data (1998–2025)
28 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $78M | +522.9% | $111M | $3.32 | 8.9% | 12.6% |
| 2024 | -$19M | -198.6% | $584,000 | $-1.04 | -3.0% | 0.1% |
| 2023 | $19M | +139.2% | $47M | $0.94 | 3.9% | 9.6% |
| 2022 | -$48M | -12.4% | -$35M | $-3.05 | -15.1% | -11.2% |
| 2021 | -$43M | -88.9% | -$40M | $-3.40 | -19.7% | -18.4% |
| 2020 | -$23M | -470.0% | -$16M | $-1.88 | -10.8% | -7.7% |
| 2019 | $6M | -60.7% | $16M | $0.50 | 3.0% | 7.9% |
| 2018 | $15M | +1540.0% | $35M | $1.32 | 7.7% | 17.5% |
| 2017 | -$1M | -127.4% | $28M | $-0.09 | -0.6% | 16.0% |
| 2016 | $4M | -74.4% | $20M | $0.34 | 3.1% | 15.6% |
See ANIP's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs ANIP Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare ANIP vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonANIP — Frequently Asked Questions
Quick answers to the most common questions about buying ANIP stock.
Is ANIP growing earnings?
ANIP EPS is $3.69, with earnings growth accelerating to +419.2%. This exceeds the 5-year CAGR of N/A. TTM net income reached $78M.
What are ANIP's profit margins?
ANI Pharmaceuticals, Inc. net margin is +8.9%, with operating margin at +12.6%. Margins sit within typical range for the sector.
How consistent are ANIP's earnings?
ANIP earnings data spans 1998-2025. The accelerating earnings trend is +419.2% YoY. Historical data enables comparison across business cycles.